BERMAN ROBERT ANDREW (Chief Executive Officer) purchased 5.7% of their position (12K shares) of ENVVENO MEDICAL CORP on the open market
Open‑market purchase worth $30.6K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/19/2024ACC: 0001493152-24-050865
DirectorOfficer· Chief Executive Officer
Since Sep 2018
+12K
Net shares
Net buyer
$30.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
12K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12K
Price / share
$2.55
Trade value
$30.60K
% of position
5.7%
12/19/2024
210.24K→222.24K
Total
Net shares
+12K
Net value
$30.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2024 | P · Purchase | +12K | $2.55 | $30.60K | 5.7% | 210.24K | 222.24K |
| Total | +12K | $30.60K | ||||||
Derivative Transactions0
No derivative transactions reported